CHURCHILL CAPITAL CORP VI-A (CCVI) Fundamental Analysis & Valuation

NYSE:CCVI • US17143W1018

10.485 USD
+0 (+0.05%)
Last: Dec 1, 2023, 08:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CCVI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CCVI. CCVI was compared to 0 industry peers in the Unkown industry. CCVI may be in some trouble as it scores bad on both profitability and health. CCVI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. CCVI Profitability Analysis

1.1 Basic Checks

  • CCVI had positive earnings in the past year.
  • CCVI had a negative operating cash flow in the past year.
CCVI Yearly Net Income VS EBIT VS OCF VS FCFCCVI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 10M 20M

1.2 Ratios

Industry RankSector Rank
ROA 3.66%
ROE 4.08%
ROIC N/A
ROA(3y)1.53%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CCVI Yearly ROA, ROE, ROICCCVI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 2 4

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CCVI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CCVI Yearly Profit, Operating, Gross MarginsCCVI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CCVI Health Analysis

2.1 Basic Checks

  • CCVI has about the same amout of shares outstanding than it did 1 year ago.
  • CCVI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CCVI Yearly Shares OutstandingCCVI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 20M 40M 60M
CCVI Yearly Total Debt VS Total AssetsCCVI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

  • CCVI has an Altman-Z score of 8.43. This indicates that CCVI is financially healthy and has little risk of bankruptcy at the moment.
  • A Debt/Equity ratio of 0.01 indicates that CCVI is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 8.43
ROIC/WACCN/A
WACCN/A
CCVI Yearly LT Debt VS Equity VS FCFCCVI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 0.26 indicates that CCVI may have some problems paying its short term obligations.
  • A Quick Ratio of 0.26 indicates that CCVI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.26
CCVI Yearly Current Assets VS Current LiabilitesCCVI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 500K 1M 1.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CCVI Growth Analysis

3.1 Past

  • CCVI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.70%.
EPS 1Y (TTM)-58.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. CCVI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 55.18, CCVI can be considered very expensive at the moment.
  • When comparing the Price/Earnings ratio of CCVI to the average of the S&P500 Index (26.69), we can say CCVI is valued expensively.
Industry RankSector Rank
PE 55.18
Fwd PE N/A
CCVI Price Earnings VS Forward Price EarningsCCVI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CCVI Per share dataCCVI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CCVI Dividend Analysis

5.1 Amount

  • CCVI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CCVI Fundamentals: All Metrics, Ratios and Statistics

CHURCHILL CAPITAL CORP VI-A

NYSE:CCVI (12/1/2023, 8:04:00 PM)

10.485

+0 (+0.05%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.26%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap433.14M
Revenue(TTM)N/A
Net Income(TTM)10.55M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 55.18
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.68
P/tB 1.68
EV/EBITDA N/A
EPS(TTM)0.19
EY1.81%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0
BVpS6.26
TBVpS6.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.66%
ROE 4.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.53%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.26
Altman-Z 8.43
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.67%
OCF growth 3YN/A
OCF growth 5YN/A

CHURCHILL CAPITAL CORP VI-A / CCVI FAQ

Can you provide the ChartMill fundamental rating for CHURCHILL CAPITAL CORP VI-A?

ChartMill assigns a fundamental rating of 1 / 10 to CCVI.


Can you provide the valuation status for CHURCHILL CAPITAL CORP VI-A?

ChartMill assigns a valuation rating of 0 / 10 to CHURCHILL CAPITAL CORP VI-A (CCVI). This can be considered as Overvalued.


What is the profitability of CCVI stock?

CHURCHILL CAPITAL CORP VI-A (CCVI) has a profitability rating of 0 / 10.


What is the valuation of CHURCHILL CAPITAL CORP VI-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CHURCHILL CAPITAL CORP VI-A (CCVI) is 55.18 and the Price/Book (PB) ratio is 1.68.


How financially healthy is CHURCHILL CAPITAL CORP VI-A?

The financial health rating of CHURCHILL CAPITAL CORP VI-A (CCVI) is 2 / 10.